In the clinical setting, the ability of LAT1 to inhibit both tumor cancer cell proliferation and stroma in colorectal tumors, which are considered to have abundant stroma, may be useful in inhibiting tumor progression. The gene discussed is SLC7A5; the disease is colorectal neoplasm.